gptkbp:instanceOf
|
oral contraceptive
|
gptkbp:activeIngredient
|
gptkb:drospirenone
ethinylestradiol
|
gptkbp:activeTabletsPerPack
|
24
|
gptkbp:approvedBy
|
gptkb:FDA
2006
|
gptkbp:containsEstrogen
|
ethinylestradiol
|
gptkbp:containsProgestin
|
gptkb:drospirenone
|
gptkbp:contraindication
|
gptkb:liver_disease
history of thromboembolic disorders
renal impairment
adrenal insufficiency
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:United_States
|
gptkbp:drugClass
|
oral contraceptive
|
gptkbp:form
|
gptkb:tablet
|
gptkbp:hasGenericVersion
|
yes
|
https://www.w3.org/2000/01/rdf-schema#label
|
YAZ
|
gptkbp:inactiveTabletsPerPack
|
4
|
gptkbp:manufacturer
|
gptkb:Bayer
|
gptkbp:marketedAs
|
Yasmin (related product)
|
gptkbp:notRecommendedFor
|
smokers over 35 years old
|
gptkbp:prescriptionStatus
|
prescription only
|
gptkbp:riskFactor
|
hypertension
hyperkalemia
venous thromboembolism
|
gptkbp:routeOfAdministration
|
oral
|
gptkbp:sideEffect
|
nausea
headache
breast tenderness
increased risk of blood clots
|
gptkbp:storage
|
store at room temperature
|
gptkbp:type
|
28 tablets per pack
|
gptkbp:usedFor
|
birth control
treatment of acne
treatment of premenstrual dysphoric disorder
|
gptkbp:bfsParent
|
gptkb:Tofino-Long_Beach_Airport
gptkb:托菲诺机场
|
gptkbp:bfsLayer
|
6
|